DENOSUMAB — all Canadian products
22 DINs
21 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DENOSUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02565951 | BILDYOS | SHANGHAI HENLIUS BIOTECH, INC. | Solution | Subcutaneous | DENOSUMAB 60 MG | Marketed | |
| 02565943 | BILDYOS | SHANGHAI HENLIUS BIOTECH, INC. | Solution | Subcutaneous | DENOSUMAB 60 MG | Approved | |
| 02567679 | BOMYNTRA | FRESENIUS KABI CANADA LTD | Solution | Subcutaneous | DENOSUMAB 120 MG | Approved | |
| 02567687 | BOMYNTRA | FRESENIUS KABI CANADA LTD | Solution | Subcutaneous | DENOSUMAB 120 MG | Approved | |
| 02567253 | BOSAYA | BIOCON BIOLOGICS CANADA INC | Solution | Subcutaneous | DENOSUMAB 60 MG | Approved | |
| 02567660 | CONEXXENCE | FRESENIUS KABI CANADA LTD | Solution | Subcutaneous | DENOSUMAB 60 MG | Approved | |
| 02566265 | DENOZA | APOTEX INC | Solution | Subcutaneous | DENOSUMAB 60 MG | Marketed | |
| 02566273 | IDENOS | APOTEX INC | Solution | Subcutaneous | DENOSUMAB 120 MG | Approved | |
| 02545411 | JUBBONTI | SANDOZ CANADA INCORPORATED | Solution | Subcutaneous | DENOSUMAB 60 MG | Marketed | |
| 02567482 | OBODENCE | SAMSUNG BIOEPIS CO., LTD | Solution | Subcutaneous | DENOSUMAB 60 MG | Approved | |
| 02569787 | ODENSIFY | JAMP PHARMA CORPORATION | Solution | Subcutaneous | DENOSUMAB 60 MG | Approved | |
| 02560895 | OSENVELT | CELLTRION INC. | Solution | Subcutaneous | DENOSUMAB 120 MG | Marketed | |
| 02343541 | PROLIA | AMGEN CANADA INC | Solution | Subcutaneous | DENOSUMAB 60 MG | Marketed | |
| 02570750 | QOSEQU | MANTRA PHARMA INC | Solution | Subcutaneous | DENOSUMAB 60 MG | Approved | |
| 02560917 | STOBOCLO | CELLTRION INC. | Solution | Subcutaneous | DENOSUMAB 60 MG | Marketed | |
| 02566001 | TUZEMTY | SHANGHAI HENLIUS BIOTECH, INC. | Solution | Subcutaneous | DENOSUMAB 120 MG | Marketed | |
| 02567261 | VEVZUO | BIOCON BIOLOGICS CANADA INC | Solution | Subcutaneous | DENOSUMAB 120 MG | Approved | |
| 02545764 | WYOST | SANDOZ CANADA INCORPORATED | Solution | Subcutaneous | DENOSUMAB 120 MG | Marketed | |
| 02566923 | XBRYK | SAMSUNG BIOEPIS CO., LTD | Solution | Subcutaneous | DENOSUMAB 120 MG | Approved | |
| 02569795 | XDENO | JAMP PHARMA CORPORATION | Solution | Subcutaneous | DENOSUMAB 120 MG | Approved | |
| 02368153 | XGEVA | AMGEN CANADA INC | Solution | Subcutaneous | DENOSUMAB 120 MG | Marketed | |
| 02343568 | PROLIA | AMGEN CANADA INC | Solution | Subcutaneous | DENOSUMAB 60 MG | Cancelled Pre Market |
Browse other molecules: